We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVV.L Regulatory News (AVV)

  • There is currently no data for AVV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission and resultant total voting rights

28 Feb 2018 07:00

RNS Number : 1177G
AVEVA Group PLC
28 February 2018
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE AND IN PART, DIRECTLY OR INDIRECTLY IN OR INTO AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

28 February 2018

 

AVEVA GROUP PLC ("AVEVA" or "the Company")

 

Admission and resultant total voting rights

 

AVEVA, a global leader in engineering and industrial software, announces that application has been made to the UK Listing Authority and the London Stock Exchange for admission of the 97,169,655 Consideration Shares to be issued to Schneider Electric Group and re-admission of the Company's 64,037,660 existing Ordinary Shares to the premium listing segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities on 1 March 2018.

 

Following admission AVEVA's share capital will be 161,207,315 ordinary shares and the total number of voting rights will be 161,207,315. Following admission the above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in the Company under the Rules.

 

 

Enquiries:

 

AVEVA

Philip Aiken

Craig Hayman

James Kidd

Matt Springett

Tel: +44 (0) 1223 55 6655

 

Lead Financial Adviser to AVEVA

Lazard

Tel: +44 (0) 20 7187 2000

Cyrus Kapadia

Richard Hoyle

Philippe Noël

 

Corporate Broker, Sponsor and Financial Adviser to AVEVA

Numis

Tel: +44 (0) 20 7260 1000

Simon Willis

Jamie Lillywhite

 

Financial PR Adviser to AVEVA

FTI Consulting

Tel: +44 (0) 20 3727 1000

Edward Bridges

 

IMPORTANT NOTICES:

Lazard & Co., Limited, which is authorised and regulated in the UK by the Financial Conduct Authority, is acting as financial adviser to AVEVA and no one else in connection with the Combination and will not be responsible to anyone other than AVEVA for providing the protections afforded to clients of Lazard & Co., Limited nor for providing advice in relation to the Combination or any other matters referred to in this announcement. Neither Lazard & Co., Limited nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard & Co., Limited in connection with this announcement, the Combination or any statement contained herein.

Numis Securities Limited ("Numis"), which is authorised and regulated in the UK by the Financial Conduct Authority, is acting as corporate broker and sponsor to AVEVA and no one else in connection with the Combination and will not be responsible to anyone other than AVEVA for providing the protections afforded to clients of Numis nor for providing advice in relation to the Combination or any other matters referred to in this announcement. Neither Numis nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Numis, in connection with this announcement, the Combination or any statement contained herein.

Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, the Republic of South Africa, Japan, the United States or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of Australian, Canadian, South African, Japanese, or US securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement or other information referred to herein comes should inform themselves about, and observe, any such restrictions.

This announcement does not constitute or form part of any offer, invitation to sell, otherwise dispose of or issue, or any solicitation of any offer to purchase or subscribe for, any shares or other securities nor shall it or any part of it, nor the fact of its distribution form the basis of, or be relied on in connection with, any contract commitment or investment decision.

This announcement has been prepared for the purpose of complying with the applicable law and regulation of the United Kingdom and information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of jurisdictions outside the United Kingdom.

This announcement does not constitute an offer of securities for sale in the United States or an offer to acquire or exchange securities in the United States. No offer to acquire securities or to exchange securities for other securities has been made, or will be made, directly or indirectly, in or into, or by use of the mails, any means or instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States or any other country in which such offer may not be made other than (i) in accordance with the tender offer requirements under the US Securities Exchange Act of 1934, as amended, or the securities laws of such other country, as the case may be, or (ii) pursuant to an available exemption from such requirements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSPGUGPPUPRGCM
Date   Source Headline
18th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20232:27 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20231:59 pmRNSForm 8.3 - AVEVA GROUP PLC
18th Jan 20231:11 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
18th Jan 202312:02 pmRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc Amend
18th Jan 202311:11 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
18th Jan 202311:00 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
18th Jan 20239:58 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
18th Jan 20239:52 amRNSForm 8.3 - Aveva Group Plc
18th Jan 20239:52 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
18th Jan 20239:10 amRNSForm 8.5 (EPT/RI)
18th Jan 20237:30 amRNSSuspension- Aveva Group PLC
17th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
17th Jan 20231:23 pmRNSForm 8.3 - AVEVA GROUP PLC
17th Jan 20231:04 pmRNSForm 8.3 - Aveva Group PLC
17th Jan 202312:28 pmRNSForm 8.3 -AVEVA GROUP PLC
17th Jan 202310:38 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
17th Jan 202310:33 amRNSISSUE AND ALLOTMENT OF NEW AVEVA SHARES
17th Jan 202310:22 amRNSForm 8.3 - Aveva Group Plc
17th Jan 202310:19 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
17th Jan 202310:10 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20233:28 pmRNSCOURT SANCTION OF SCHEME
16th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
16th Jan 20231:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
16th Jan 202311:24 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
16th Jan 202311:17 amRNSForm 8.3 - AVEVA GROUP PLC
16th Jan 202311:14 amRNSForm 8.3 - Aveva Group Plc
16th Jan 202310:12 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
16th Jan 202310:05 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20238:53 amRNSForm 8.5 (EPT/RI)
13th Jan 20236:12 pmRNSAveva Group
13th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
13th Jan 20231:33 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
13th Jan 202311:20 amRNSForm 8.3 - AVEVA GROUP PLC
13th Jan 202310:26 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
13th Jan 202310:18 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
13th Jan 202310:15 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
13th Jan 20239:01 amRNSForm 8.5 (EPT/RI)
13th Jan 20237:00 amRNSForm 8.3 - AVEVA GROUP PLC Amend
12th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20233:06 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20231:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
12th Jan 202312:05 pmRNSForm 8.3 - AVEVA GROUP PLC
12th Jan 202311:23 amRNSForm 8.5 (EPT/RI) Aveva Group Plc
12th Jan 202310:28 amBUSForm 8.3 - AVV LN Equity 11-January-23 Decrease in Traded Position Disclosure
12th Jan 202310:23 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
12th Jan 202310:17 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
12th Jan 20238:35 amRNSForm 8.5 (EPT/RI)
11th Jan 20236:00 pmRNSAveva Group
11th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.